Gérard Siest

发表

Conference Scene: Systems biology and personalized health science and translation.

Gérard Siest, Ndeye Coumba Ndiaye, Said El Shamieh, 2013, Pharmacogenomics.

Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable results

Gérard Siest, Harald Tammen, Giampaolo Merlini, 2007, Proteomics. Clinical applications.

Progress in pharmacogenetics: consortiums and new strategies

Joaquín Dopazo, Munir Pirmohamed, Gérard Siest, 2016, Drug metabolism and personalized therapy.

"…it appears to be important not only to foster translational research, but also to enable the concurrent development and implementation of the necessary educational tools."

Gérard Siest, 2009 .

Family Studies: Their Role in the Evaluation of Genetic Cardiovascular Risk Factors

Gérard Siest, Sophie Visvikis, G. Siest, 2002, Clinical chemistry and laboratory medicine.

Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study.

Frédéric Fumeron, Gérard Siest, Sophie Visvikis-Siest, 2005, The American journal of clinical nutrition.

Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study

Gérard Siest, Sophie Visvikis, G. Siest, 2003, Neuroscience Letters.

Heparin specifically inhibits binding of apolipoprotein E to amyloid β-peptide

Gérard Siest, G. Siest, Vladimir V Shuvaev, 2000, Neuroscience Letters.

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.

Gérard Siest, Sophie Visvikis-Siest, Sandy Maumus, 2005, European journal of pharmacology.

Intima–media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure

Gérard Siest, Olivier Chapet, Sophie Visvikis, 1998, Journal of hypertension.